• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴瘤患者生存率的改善存在种族、年龄和性别差异:一项基于人群的研究结果。

Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study.

机构信息

Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, United States of America.

Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai School of Medicine, New York, NY, United States of America.

出版信息

PLoS One. 2018 Jul 11;13(7):e0199745. doi: 10.1371/journal.pone.0199745. eCollection 2018.

DOI:10.1371/journal.pone.0199745
PMID:29995909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6040734/
Abstract

OBJECTIVE

To evaluate improvement in survival of lymphoma patients from 1990 to 2014, stratified by age, sex and race using Surveillance Epidemiology and End-Result Survey Program (SEER) data.

STUDY DESIGN AND SETTING

We identified 113,788 incident lymphoma cases from nine SEER cancer registries were followed up for cause-specific mortality from lymphoma. Cox proportional hazard regression was used to estimate hazard ratios (HRs) and their respective 95% confidence interval (CIs) for various time periods within groups stratified by race, age and sex.

RESULTS

Five-year survival for Hodgkin's lymphoma (HL) was 89% for patients 20-49 years of age. For this age group, compared to 1990-1994, survival significantly improved in 2000-2004 (HR = 0.65; 95% CI: 0.54-0.78), 2005-2009 (HR = 0.46, 95% CI: 0.38-0.57) and 2010-2014 (HR = 0.29, 95% CI: 0.20-0.41). Hodgkin's lymphoma patients aged 75-85 years had 5-year survival of 37% and in these patients, compared to 1990-1994, survival only improved from 2005 onward (HR = 0.67, 95% CI: 0.50-0.90). In patients with non-Hodgkin's Lymphoma (NHL), all age groups showed survival improvements between 1990-1994 period and 2010-2014 period. Improvements in HL and NHL survival were seen for all race categories and both genders.

CONCLUSION

Survival among US lymphoma patients has improved substantially between 1990-1994 period and 2010-2014 period, though disease-specific mortality was still higher in older age groups.

摘要

目的

利用监测、流行病学和最终结果调查计划(SEER)的数据,按年龄、性别和种族对 1990 年至 2014 年淋巴瘤患者的生存率进行分层评估。

研究设计和地点

我们从九个 SEER 癌症登记处确定了 113788 例淋巴瘤新发病例,随访了这些患者的淋巴瘤特异性死亡原因。采用 Cox 比例风险回归估计了不同种族、年龄和性别亚组内不同时间段的风险比(HR)及其各自的 95%置信区间(CI)。

结果

20-49 岁霍奇金淋巴瘤(HL)患者的 5 年生存率为 89%。对于该年龄组,与 1990-1994 年相比,2000-2004 年(HR=0.65;95%CI:0.54-0.78)、2005-2009 年(HR=0.46,95%CI:0.38-0.57)和 2010-2014 年(HR=0.29,95%CI:0.20-0.41)生存率显著提高。75-85 岁霍奇金淋巴瘤患者的 5 年生存率为 37%,与 1990-1994 年相比,仅从 2005 年开始生存率有所提高(HR=0.67,95%CI:0.50-0.90)。非霍奇金淋巴瘤(NHL)患者中,所有年龄组在 1990-1994 年与 2010-2014 年期间生存率均有所提高。HL 和 NHL 生存率的提高在所有种族类别和性别中均可见。

结论

1990-1994 年至 2010-2014 年期间,美国淋巴瘤患者的生存率有了显著提高,尽管年龄较大的患者的疾病特异性死亡率仍然较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb99/6040734/3ccbdaf3a4a2/pone.0199745.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb99/6040734/97a0570bbf6a/pone.0199745.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb99/6040734/1cfd0fececc6/pone.0199745.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb99/6040734/3ccbdaf3a4a2/pone.0199745.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb99/6040734/97a0570bbf6a/pone.0199745.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb99/6040734/1cfd0fececc6/pone.0199745.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb99/6040734/3ccbdaf3a4a2/pone.0199745.g003.jpg

相似文献

1
Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study.淋巴瘤患者生存率的改善存在种族、年龄和性别差异:一项基于人群的研究结果。
PLoS One. 2018 Jul 11;13(7):e0199745. doi: 10.1371/journal.pone.0199745. eCollection 2018.
2
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).纳武单抗用于成人霍奇金淋巴瘤(使用RobotReviewer软件进行的快速综述)
Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2.
5
Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.早期霍奇金淋巴瘤成人患者单纯化疗与化疗联合放疗的比较
Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD007110. doi: 10.1002/14651858.CD007110.pub3.
6
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.对早期预后不良或晚期霍奇金淋巴瘤患者,比较包括强化BEACOPP方案的一线化疗与包括ABVD方案的化疗。
Cochrane Database Syst Rev. 2017 May 25;5(5):CD007941. doi: 10.1002/14651858.CD007941.pub3.
7
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
8
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Exercise for intermittent claudication.间歇性跛行的运动疗法
Cochrane Database Syst Rev. 2017 Dec 26;12(12):CD000990. doi: 10.1002/14651858.CD000990.pub4.

引用本文的文献

1
Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic review.社会人口学决定因素对当代淋巴瘤临床试验入组情况的影响:一项系统综述
Oncologist. 2025 Jun 4;30(6). doi: 10.1093/oncolo/oyaf180.
2
Etiology of non-Hodgkin lymphoma: A review from epidemiologic studies.非霍奇金淋巴瘤的病因:来自流行病学研究的综述
J Natl Cancer Cent. 2022 Aug 17;2(4):226-234. doi: 10.1016/j.jncc.2022.08.003. eCollection 2022 Dec.
3
Racial Disparities in Survival Among Non-Hodgkin Lymphoma Patients: An Analysis of the SEER Database (2007-2015).

本文引用的文献

1
Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013.2000年至2013年美国儿童、成人和老年人伯基特淋巴瘤的生存预测因素
Int J Cancer. 2017 Apr 1;140(7):1494-1502. doi: 10.1002/ijc.30576. Epub 2017 Jan 9.
2
Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma.培门冬酶、吉西他滨和奥沙利铂(P-GEMOX)化疗联合放疗在新诊断的IE期至IIE期鼻型结外自然杀伤/T细胞淋巴瘤中的疗效
Hematology. 2017 Jul;22(6):320-329. doi: 10.1080/10245332.2016.1264163. Epub 2016 Dec 5.
3
非霍奇金淋巴瘤患者生存的种族差异:监测、流行病学和最终结果(SEER)数据库(2007 - 2015年)分析
Cureus. 2022 Jun 12;14(6):e25867. doi: 10.7759/cureus.25867. eCollection 2022 Jun.
4
Predictive Model for Overall Survival and Cancer-Specific Survival in Patients with Esophageal Adenocarcinoma.食管腺癌患者总生存期和癌症特异性生存期的预测模型
J Oncol. 2021 Sep 14;2021:4138575. doi: 10.1155/2021/4138575. eCollection 2021.
5
Sampling-based estimation for massive survival data with additive hazards model.基于抽样的加性风险模型在海量生存数据分析中的估计。
Stat Med. 2021 Jan 30;40(2):441-450. doi: 10.1002/sim.8783. Epub 2020 Nov 3.
6
Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period.1973-2014 年期间美国成年人白血病存活率的种族/民族、年龄和性别差异。
PLoS One. 2019 Aug 19;14(8):e0220864. doi: 10.1371/journal.pone.0220864. eCollection 2019.
7
Cancer statistics for adults aged 85 years and older, 2019.2019 年 85 岁及以上成年人癌症统计数据。
CA Cancer J Clin. 2019 Nov;69(6):452-467. doi: 10.3322/caac.21577. Epub 2019 Aug 7.
Survival Differences by Race/Ethnicity and Neighborhood Socioeconomic Status in Adolescents and Young Adults Diagnosed with Non-Hodgkin Lymphoma.
青少年和青年非霍奇金淋巴瘤患者按种族/民族及邻里社会经济地位划分的生存差异
J Adolesc Young Adult Oncol. 2015 Jun;4(2):76-83. doi: 10.1089/jayao.2014.0037.
4
Occupation and Risk of Non-Hodgkin Lymphoma and Its Subtypes: A Pooled Analysis from the InterLymph Consortium.职业与非霍奇金淋巴瘤及其亚型的风险:来自InterLymph联盟的汇总分析。
Environ Health Perspect. 2016 Apr;124(4):396-405. doi: 10.1289/ehp.1409294. Epub 2015 Sep 4.
5
Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.美国国家癌症研究所监测、流行病学和最终结果(SEER)项目 1990 年至 2010 年的数据显示,主要癌症患者的生存率在种族、年龄和性别方面存在差异。
JAMA Oncol. 2015 Apr;1(1):88-96. doi: 10.1001/jamaoncol.2014.161.
6
US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma.美国青少年和青年非霍奇金淋巴瘤患者生存差异的趋势。
Cancer Causes Control. 2015 Aug;26(8):1153-62. doi: 10.1007/s10552-015-0609-1. Epub 2015 Jun 18.
7
Trends in cancer diagnoses and survival among persons with AIDS in a high HIV prevalence urban area.艾滋病高流行城市地区艾滋病患者的癌症诊断和生存趋势。
AIDS Care. 2015;27(7):860-9. doi: 10.1080/09540121.2015.1011074. Epub 2015 Feb 25.
8
Radiation treatment in older patients: a framework for clinical decision making.老年患者的放射治疗:临床决策框架
J Clin Oncol. 2014 Aug 20;32(24):2669-78. doi: 10.1200/JCO.2014.55.1168. Epub 2014 Jul 28.
9
Cancer treatment disparities in HIV-infected individuals in the United States.美国 HIV 感染者癌症治疗差异。
J Clin Oncol. 2014 Aug 1;32(22):2344-50. doi: 10.1200/JCO.2013.54.8644. Epub 2014 Jun 30.
10
Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.弥漫性大 B 细胞淋巴瘤在现代治疗时代的死亡率存在社会经济差异。
Blood. 2014 Jun 5;123(23):3553-62. doi: 10.1182/blood-2013-07-517110. Epub 2014 Apr 4.